| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/07/2007 | CN1923810A Chemical synthesis method of 4-amino-3,5,6-trichloropyridine-2-formic acid |
| 03/07/2007 | CN1923365A Method for producing indolopyrrolocarbazole derivative |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/07/2007 | CN1302777C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 03/07/2007 | CN1302776C Peptide arginals and methods for treating disseminated intravascular coagulation |
| 03/06/2007 | US7186843 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186750 Optically active maleimide derivatives, optically active polymaleimide derivatives, process for their production, separating media comprising the optically active polymaleimide derivatives and method of separating optically active compounds using them |
| 03/06/2007 | US7186749 plasminogen activator inhibitors such as 3-phenyl-2-{[6-(5-phenyl-1H-pyrrol-2-yl)-2-naphthyl]oxy}propanoic acid, used for treating cardiovascular disorders |
| 03/06/2007 | US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 03/06/2007 | US7186747 enzyme inhibitors comprising heterocyclic amides, used for prevention of viral diseases |
| 03/06/2007 | US7186739 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers |
| 03/06/2007 | US7186735 Vasodilation; cardiovascular disorders; anticoagulants |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007024833A1 Anthranilamides for controlling invertebrate pests |
| 03/01/2007 | WO2007024113A1 Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity |
| 03/01/2007 | WO2007023824A1 Process for production of aralkyloxypyrrolidine derivative |
| 03/01/2007 | WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 03/01/2007 | WO2006119713A3 Antineoplastic compounds and pharmaceutical compositions thereof |
| 03/01/2007 | WO2006116157A9 Dipeptidyl peptidase-iv inhibitors |
| 03/01/2007 | WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors |
| 03/01/2007 | US20070049759 Methods for Preparing N-Arylated Oxazolidinones Via A Copper Catalyzed Cross Coupling |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 03/01/2007 | US20070045622 N-sulfonylaminocarbonyl containing compounds |
| 03/01/2007 | US20070044254 Novel 2,6-disubstituted primary para-phenylenediamines and process for their use in the oxidation dyeing of keratin fibers |
| 03/01/2007 | CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 02/28/2007 | EP1757583A1 Process for producing cyclic n-hydroxyimide compound |
| 02/28/2007 | EP1757582A1 Arylalkylamines and process for production thereof |
| 02/28/2007 | EP1756119A1 Collection of traceable compounds and uses thereof |
| 02/28/2007 | EP1756115A2 A new route to formyl-porphyrins |
| 02/28/2007 | EP1756107A2 Aryl-substituted piperazine derivatives |
| 02/28/2007 | EP1756106A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/28/2007 | EP1756101A2 Androgen receptor modulators and method of treating disease using the same |
| 02/28/2007 | EP1756095A2 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756053A1 Process for the preparation of atorvastatin |
| 02/28/2007 | EP1756052A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 02/28/2007 | EP1756051A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/28/2007 | EP1756050A1 Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | EP1756038A1 Synthesis of amino-alkoxy-heptanoic alkyl ester |
| 02/28/2007 | EP1755593A1 Naphthaline derivatives useful as histamine-3-receptor ligands |
| 02/28/2007 | EP1501795B1 Cinnamic acid amides |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | CN1922482A Detection cartridges, modules, systems and methods |
| 02/28/2007 | CN1922481A Acoustic sensors and methods |
| 02/28/2007 | CN1922480A Acousto-mechanical detection systems and methods of use |
| 02/28/2007 | CN1922177A Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors |
| 02/28/2007 | CN1922149A Pyrrole and pyrazole daao inhibitors |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1922138A Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1922137A Protease inhibitors |
| 02/28/2007 | CN1921907A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 02/28/2007 | CN1921858A Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
| 02/28/2007 | CN1921847A 氨基醇化合物 Amino alcohol compound |
| 02/28/2007 | CN1921845A Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183417 Which has antitumor activity; starting from (2S, 3R)-methyl 2-(4-methoxybenzamido)-3-hydroxybutanoate and cyclizing to Methyl 4,5-dihydro-2 (4-methoxyphenyl)-5-methyloxazole-4-carboxylate |
| 02/27/2007 | US7183408 calcium atorvastatin (Lipitor) intermediate; from claimed intermediate 5-(4-fluorophenyl)-2-isopropyl-1-(3-morpholin-4-yl-3-oxo-propyl)-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide; via diol esters from the 1,3,5-tricarbonyl precursors in a stereoselective ruthenium-catalyzed hydrogenation |
| 02/27/2007 | US7183323 Sodium channel modulators |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183292 Substituted pyrrolidine and related compounds |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/27/2007 | US7183059 Selecting desired synthetic precursors having defined stereochemical relationships, reacting precursors to obtain compound having specific stereochemistry, repeating selecting and reacting until desired library is obtained |
| 02/22/2007 | WO2007020502A2 Cannabinoid receptor ligands and uses thereof |
| 02/22/2007 | WO2007020421A1 Crystalline and amorphous sodium atorvastatin |
| 02/22/2007 | WO2007020413A1 Crystalline and amorphous sodium atorvastatin |
| 02/22/2007 | WO2006093547A3 Novel lipoxygenase inhibitors |
| 02/22/2007 | WO2006032959A3 Processes for the preparation of pyrrole derivatives |
| 02/22/2007 | WO2006014549A8 Synthesis of azo bonded immunoregulatory compounds |
| 02/22/2007 | US20070043221 exemplified by Pyrrole Ester O-benzyl lactol methyl acetal |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043015 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 02/22/2007 | US20070042271 such as N-methyl-N-methoxymethylpyrrolidinium chloride; high solubility in organic solvents, high voltage resistance and high electrical conductivity |
| 02/22/2007 | US20070042109 Conversion of amine- to carboxyl groups on solid surfaces |
| 02/22/2007 | US20070039107 For dyeing keratin fibres which are capable of giving more intense and yet unselective colorations which show good resistance to the various attacking factors to which the hair may be subjected |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2619486A1 Crystalline and amorphous sodium atorvastatin |
| 02/22/2007 | CA2619040A1 Crystalline and amorphous sodium atorvastatin |
| 02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/21/2007 | EP1753805A1 Biological molecule-reactive hydrophilic silicone surface |
| 02/21/2007 | EP1753748A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 02/21/2007 | EP1753724A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 02/21/2007 | EP1753722A2 Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine |
| 02/21/2007 | EP1753719A1 Substituted pyrrolidine-2-ones |